Loughborough University
Leicestershire, UK
LE11 3TU
+44 (0)1509 263171
Loughborough University

Loughborough University Institutional Repository

Please use this identifier to cite or link to this item: https://dspace.lboro.ac.uk/2134/23482

Title: Automating decentralized manufacturing of cell and gene therapy products.
Authors: Harrison, Richard P.
Rafiq, Qasim A.
Medcalf, Nick
Issue Date: 2016
Publisher: © The Authors. Published by BioInsights Publishing
Citation: HARRISON, R.P., RAFIQ, Q.A. and MEDCALF, N., 2016. Automating decentralized manufacturing of cell and gene therapy products. Cell & Gene Therapy Insights, 2(1), pp. 115-120.
Abstract: Decentralized, or redistributed manufacture, is likely to be the manufacturing approach of choice for some cell- and gene-based therapies, in particular, personalized therapies. Such an approach will ultimately depend on the business model and will take into account the regulatory and supply chain factors. Advances in technology and integration of automated production platforms have demonstrated the potential for decentralized manufacturing, however there is a need to extend the scope of automation across the entire process including the cell isolation, distribution, tracking, administration, quality management systems and development of automated analytical techniques to facilitate real-time release. For decentralized manufacture to be successfully integrated for cell and gene therapy production, lessons from other accepted healthcare-associated models of manufacture can provide useful insights and perspectives to make informed decisions. Such models share similar characteristics to decentralized manufacture in that they are patient-specific and have a limited time-frame for administration. These existing approaches, which have successfully incorporated aspects of automation, can provide a blueprint for success and may expedite the decentralization of patient-specific cell and gene therapy manufacture.
Description: This is an Open Access Article. It is published by BioInsights Publishing under the Creative Commons Attribution 4.0 NonCommercial – NoDerivatives Licence (CC BY-NC-ND). Full details of this licence are available at: http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor: This work has received funding from the EPSRC under Grant EPIM017559/1 as part of the project “Cell Microfactories: A Feasibility Study in the Redistributed Manufacture of Cell-Based Therapeutics”. The work has also received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 667932.
Version: Published
DOI: 10.18609/cgti.2016.014
URI: https://dspace.lboro.ac.uk/2134/23482
Publisher Link: http://dx.doi.org/10.18609/cgti.2016.014
ISSN: 2059-7800
Appears in Collections:Published Articles (Mechanical, Electrical and Manufacturing Engineering)

Files associated with this item:

File Description SizeFormat
Published copy with acknowledgements.pdfPublished version239.86 kBAdobe PDFView/Open

 

SFX Query

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.